Effect of eight-week online cognitive training in Parkinson's disease: A double-blind, randomized, controlled trial

被引:13
|
作者
van Balkom, Tim D. [1 ,2 ]
Berendse, Henk W. [3 ]
van der Werf, Ysbrand D. [2 ]
Twisk, Jos W. R. [4 ]
Peeters, Carel F. W. [5 ]
Hoogendoorn, Adriaan W. [6 ]
Hagen, Rob H. [7 ]
Berk, Tanja [7 ]
van den Heuvel, Odile A. [1 ,2 ]
Vriend, Chris [1 ,2 ]
机构
[1] Vrije Univ Amsterdam, Amsterdam Neurosci, Psychiat, Amsterdam UMC, POB 7057, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Amsterdam Neurosci, Anat & Neurosci, Amsterdam UMC, POB 7057, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Amsterdam Neurosci, Neurol, Amsterdam UMC, POB 7057, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Amsterdam Publ Hlth, Epidemiol & Biostat, Amsterdam UMC, POB 7057, Amsterdam, Netherlands
[5] Wageningen Univ & Res, Math & Stat Methods Grp Biometris, POB 16, NL-6700 AA Wageningen, Netherlands
[6] GGZ InGeest, Res & Innovat, Oldenaller 1, NL-1081 HL Amsterdam, Netherlands
[7] Dutch Parkinsons Dis Assoc, POB 46, NL-3980 CA Bunnik, Netherlands
关键词
Parkinson's disease; Cognitive training; RCT; Cognitive impairment; Dementia; Cognitive rehabilitation; DIAGNOSTIC-CRITERIA; IMPAIRMENT; DISORDER; DECLINE; BRAIN;
D O I
10.1016/j.parkreldis.2022.02.018
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Cognitive training (CT) has been proposed as a treatment option for cognitive impairment in Parkinson's disease (PD). We aimed to assess the efficacy of adaptive, computerized CT on cognitive function in PD. Methods: In this double-blind, randomized controlled trial we enrolled PD patients that experienced substantial subjective cognitive complaints. Over a period of eight weeks, participants underwent 24 sessions of computerized multi-domain CT or an active control intervention for 45 min each (randomized 1:1). The primary outcome was the accuracy on the Tower of London task; secondary outcomes included effects on other neuropsychological outcomes and subjective cognitive complaints. Outcomes were assessed before and after training and at six-months follow-up, and analyzed with multivariate mixed-model analyses. Results: The intention-to-treat population consisted of 136 participants (n = 68 vs. n = 68, age M: 62.9y, female: 39.7%). Multivariate mixed-model analyses showed no group difference on the Tower of London accuracy corrected for baseline performance (n = 130): B: 0.06, 95% CI: 0.27 to 0.15, p = 0.562. Participants in the CT group were on average 0.30 SD (i.e., 1.5 s) faster on difficulty load 4 of this task (secondary outcome): 95% CI: 0.55 to 0.06, p = 0.015. CT did not reduce subjective cognitive complaints. At follow-up, no group differences were found. Conclusions: This study shows no beneficial effect of eight-week computerized CT on the primary outcome (i.e., planning accuracy) and only minor improvements on secondary outcomes (i.e., processing speed) with limited clinical impact. Personalized or ecologically valid multi-modal intervention methods could be considered to achieve clinically meaningful and lasting effects.
引用
收藏
页码:80 / 87
页数:8
相关论文
共 50 条
  • [11] A randomized, double-blind, placebo-controlled trial of hydrogen water in Parkinson's disease
    Yoritaka, A.
    Takanashi, M.
    Hirayama, M.
    Ohta, S.
    Hattori, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 311 - 311
  • [12] Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients
    Stern, MB
    Marek, KL
    Friedman, J
    Hauser, RA
    LeWitt, PA
    Tarsy, D
    Olanow, CW
    MOVEMENT DISORDERS, 2004, 19 (08) : 916 - 923
  • [13] A Double-Blind, Randomized, Controlled Trial of Lovastatin in Early-Stage Parkinson's Disease
    Lin, Chin-Hsien
    Chang, Chin-Hao
    Tai, Chun-Hwei
    Cheng, Mei-Fang
    Chen, Yi-Chieh
    Chao, Ying-Ting
    Huang, Tse-Le
    Yen, Ruoh-Fang
    Wu, Ruey-Meei
    MOVEMENT DISORDERS, 2021, 36 (05) : 1229 - 1237
  • [14] A Randomized, Double-Blind, Placebo-Controlled Trial of Levetiracetam for Dyskinesia in Parkinson's Disease
    Wong, Kitty K.
    Alty, Jane E.
    Goy, Amanda G.
    Raghav, Sanjay
    Reutens, David C.
    Kempster, Peter A.
    MOVEMENT DISORDERS, 2011, 26 (08) : 1552 - 1555
  • [15] A randomized double-blind placebo-controlled trial of probiotics for constipation in Parkinson's disease
    Chong, K. K.
    Lim, S. Y.
    Manap, M. A. A. A.
    Lim, J. L.
    Low, S. C.
    Mahadeva, S. K.
    Tan, A. H.
    MOVEMENT DISORDERS, 2018, 33 : S194 - S194
  • [16] A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
    Richard, I. H.
    McDermott, M. P.
    Kurlan, R.
    Lyness, J. M.
    Como, P. G.
    Pearson, N.
    Factor, S. A.
    Juncos, J.
    Ramos, C. Serrano
    Brodsky, M.
    Manning, C.
    Marsh, L.
    Shulman, L.
    Fernandez, H. H.
    Black, K. J.
    Panisset, M.
    Christine, C. W.
    Jiang, W.
    Singer, C.
    Horn, S.
    Pfeiffer, R.
    Rottenberg, D.
    Slevin, J.
    Elmer, L.
    Press, D.
    Hyson, H. C.
    McDonald, W.
    NEUROLOGY, 2012, 78 (16) : 1229 - 1236
  • [17] Treatment of Neuropsychiatric Symptoms in Parkinson's Disease With Botulinum Toxin A: A 12 week Randomized, Double-Blind, Placebo-Controlled Trial
    Zhu, Xiaofeng
    Wei, Ming
    Wang, Lijun
    Tong, Qiang
    Yang, Xiu
    Han, Qiu
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2025, 38 (03) : 223 - 231
  • [18] Effects of cognitive training in Parkinson's disease: A randomized controlled trial
    Petrelli, Annette
    Kaesberg, Stephanie
    Barbe, Michael T.
    Timmermann, Lars
    Fink, Gereon R.
    Kessler, Josef
    Kalbe, Elke
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (11) : 1196 - 1202
  • [19] A double-blind randomized controlled trial to assess the effect of bright light therapy on depression in patients with Parkinson’s disease
    Sonja Rutten
    Chris Vriend
    Jan H. Smit
    Henk W. Berendse
    Adriaan W. Hoogendoorn
    Odile A. van den Heuvel
    Ysbrand D. van der Werf
    BMC Psychiatry, 16
  • [20] A double-blind randomized controlled trial to assess the effect of bright light therapy on depression in patients with Parkinson's disease
    Rutten, Sonja
    Vriend, Chris
    Smit, Jan H.
    Berendse, Henk W.
    Hoogendoorn, Adriaan W.
    van den Heuvel, Odile A.
    van der Werf, Ysbrand D.
    BMC PSYCHIATRY, 2016, 16